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Purpose: To analyze cytokines in the retina and serum in an experimental model of central retinal artery occlusion (CRAO)
in mice.
Methods: CRAO was induced by laser activation of intravenously injected rose bengal, a photosensitive dye, in 60 C57Bl/
6 mice. mRNA and protein levels of macrophage inhibitory protein-2 (MIP-2), interleukin-6 (IL-6), and tumor necrosis
factor- α (TNF-α) were analyzed using real-time polymerase chain reaction, and western blot, respectively. Cytokine
levels in serum were measured by ELISA. Analysis was performed at various time intervals from CRAO induction.
Results: In the retina, MIP-2 and IL-6 mRNA expression decreased 3 h after induction of CRAO and increased thereafter,
peaking at 12–24 h. By 7 days, levels were again mostly undetectable. TNF-α mRNA expression increased at 3 h and
decreased to control levels at 7 days. At the protein level, all cytokines were present at 3 h, following similar patterns to
their respective gene expression thereafter. In serum, MIP-2 and TNF-α levels peaked early, and decreased to control
levels at 12 h, with a second late rise of TNF-α. IL-6 levels increased between 3 and 12 h and decreased at 24 h.
Conclusions: Temporal variations in cytokines were observed following the induction of CRAO, both at the retinal mRNA
expression and protein levels. These temporal changes, and the variable effects of the cytokines at the different time
intervals, should be taken into account during the formulation of therapeutic strategies.
Acute central retinal artery occlusion (CRAO) can cause
severe and irreversible visual loss. The outcome depends on
the vessel occluded and the duration of the occlusion [1]. In
an experimental model of CRAO in rhesus monkeys, Hayreh
et al. [2] demonstrated a retinal tolerance to acute ischemic
occlusion lasting up to 100 min. However, occlusion longer
than 240 min caused massive irreversible retinal damage, with
total optic nerve atrophy and nerve fiber layer loss [2–4].
Understanding  the  mechanisms  underlying  the  temporal
differences in ischemic damage can help researchers develop
appropriate interventions.
The  role  of  inflammation  in  the  pathogenesis  of
spontaneous and experimentally induced ischemic events is
well  established  [5–8].  Arterial  occlusion  triggers  tissue
ischemia  and  a  subsequent  inflammatory  reaction  by  the
production  of  cytokines  and  adhesion  molecules,  either
locally or systemically [9,10]. An elevation in inflammatory
marker levels has been reported following acute ischemic
events  in  various  organs  [5,6],  including  the  eye  [11,12].
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Thrombotic events have been specifically correlated with an
increase  in  the  proinflammatory  cytokines,  interleukin  8
(IL-8), tumor necrosis factor alpha (TNF-α), and interleukin
6 (IL-6) [12–15]. Changes in the levels of these cytokines were
found within minutes to hours of the ischemic event [16,17].
In previous clinical studies, we reported changes in the
levels of the proinflammatory cytokines in the aqueous humor
and serum of patients with CRAO [12] and in the serum of
patients with anterior ischemic optic neuropathy [11]. We
assumed that temporal changes in the levels of these cytokines
in  the  aqueous  humor  may  reflect  local  changes  in  the
ischemic retina [18].
Since clinical studies of CRAO are limited by the rarity
of the event and the availability of tissue, in the present study,
we  examined  the  temporal  changes  in  proinflammatory
cytokines in an experimental model of CRAO. Researchers
have described the technique of laser photoactivation of an
injected dye to induce retinal artery occlusion in rabbits [19]
and rats [20,21]. We modified the model of Daugeliene et al.
[20],  which  involves  the  injection  of  rose  bengal,  a
photosensitive dye that releases active oxygen radicals when
irradiated by a green light. In a previous study, we validated
the  experimental  model  and  described  the  clinical,
angiographic, histologic, and molecular changes of CRAO in
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885mice [22]. Owing to the similarities found to human CRAO,
we  were  able  to  apply  the  model  to  the  investigation  of
additional  parameters  of  this  ischemic  condition.  In  the
present  study,  we  analyzed  the  gene  expression  of
proinflammatory cytokines in the retina, verified at the protein
level, and the levels of the same cytokines in the serum, at
different  time  points  after  induction  of  CRAO,  and  then
correlated  the  cytokine  profile  with  previous  findings  in
clinical and experimental ocular ischemic conditions.
METHODS
All protocols were conducted in accordance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research. Every animal protocol was approved and monitored
by the Animal Care Committee of Rabin Medical Center.
CRAO mouse model: Adult male C57bl/6 mice (25–30 g)
purchased from Harlan Laboratories (Jerusalem, Israel) were
housed under a 14 h light/10 h dark cycle with standard chow
and water ad libitum. CRAO was induced in 60 C57Bl/6 mice.
This model was previously validated in our laboratory on the
basis  of  clinical  findings,  fluorescein  angiography,  and
histopathologic study, and further characterized by ischemic
gene expression [22].
The right eye of each animal was treated, and the left eye
served as an internal control for retinal levels of expression.
Negative controls for serum levels consisted of naive mice and
mice  injected  with  rose  bengal  without  laser  treatment.
Findings were also compared between mice with moderate or
severe occlusion.
Induction  of  mouse  CRAO:  The  method  of  CRAO
induction was described in detail in our previous report [21].
Briefly,  CRAO  was  induced  in  C57Bl/6  mice  by  laser
photoactivation of intravenously injected rose Bengal (Sigma
Aldrich, St. Louis, MO) dye (0.05 ml of 2.5 mM). The laser
beam was directed at the central retinal artery, at the point at
which it emerges from the optic nerve head. The retina was
visualized directly with the help of a custom-designed fundus
corneal contact lens. YAG laser (514 nm) was used, with the
following specifications: 200 μm spot size, 20 shots of 0.1 s
duration, 100 mW power for moderate occlusion, and 150 mW
power for severe occlusion.
Quantification of cytokine expression in the retina:
mRNA  expression—The  expression  of  the
proinflammatory cytokines in the retina was measured at 3 h,
12 h, 24 h, and 7 days after CRAO induction. Immediately
after  euthanasia,  using  CO2  inhalation,  the  eyes  were
enucleated and the retinas were snap frozen in liquid nitrogen.
Total RNA was extracted using TRIzolTM reagent (Invitrogen,
Life  Technologies,  Carlsbad,  CA)  and  reverse-transcribed
into cDNA using random hexamers (Amersham Biosciences,
Little  Chalfont,  UK)  and  MMLV-reverse  transcriptase
(Promega, Madison, WI). cDNA was analyzed by real time
RT–PCR using the Sequence Detection System (ABI Prism
7900;  Applied  Biosystems,  Inc.  Foster  City,  CA).  The
expression of MIP-2 (the murine equivalent of human IL-8)
and  of  IL-6,  and  TNF-α  was  measured.  Mouse  beta-actin
(ACTB) was used as the reference gene to normalize cDNA
input levels. The primer pairs are shown in Table 1. Reactions
were performed in a 20 µl volume containing 4 µl cDNA, 1 µl
each of forward and reverse primers, and buffer included in
the master mix (SYBR® Green I; Applied Biosystems, Inc.).
PCR cycling conditions were as follows: initial denaturation
step of 95 °C for 10 min followed by 40 cycles of 1 min
denaturation at 95 °C and 1 min of annealing and extension at
60 °C. Duplicate transcriptase-based quantitative PCR (RT-
QPCR) reactions (Prism 7900; Applied Biosystems) were
performed  for  each  cytokine  to  minimize  individual  tube
variability, and an average was taken for each time point.
Standard curves for PCR assays were obtained using cDNA
extracted from tissues normally producing each cytokine in
naive mice (kidney for MIP-2, heart for IL-6, and spleen for
TNF-α). Results were quantified and presented as relative
values of the nonischemic eye using a comparative Ct (2-ΔΔCt)
method  [23],  where  ΔΔCt=ΔCt  (sample)–ΔCt  (reference
gene).
Protein  levels  using  Western-blot  analysis—Protein
analysis was performed from 3 to 5 retinal samples of the same
mice, at each of the following time points: 3 h, 12 h, and 7
days.  All  equipment  for  protein  gel  electrophoresis  was
purchased from Biorad Laboratories (Hercules, CA). Proteins
were in Trizol® (Invitrogen), following mRNA extraction,
therefore an appropriate protocol was used. Due to the small
quantity of extracted material which was previously analyzed
for gene expression, the samples of each time point were
pooled. Protein samples were prepared and separated using a
TABLE 1. PRIMER SEQUENCES
Gene Forward (5′3′) Reverse (3′5′)
TNF-α TCTCAAAATTCGAGTGACAAGC ACTCCAGCTGCTCCTCCAC
IL-6 GTTCTCTGGGAAATCGTGGA TTCTGCAAGTGCATCATCGT
MIP-2 GCGCCCAGACAGAAGTCATAG GGCAAACTTTTTGACCGCC
Enlisted in the table are the pairs of primers for each of the following genes (TNF-α, IL-6, MIP-2) used for RT PCR to measure
levels of mRNA expression in the mouse retina.
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88612% acryl-amide SDS–PAGE gel. Nitrocellulose membranes
were prepared by soaking in wetting solution (25 mM tris/
glycine  [Biorad  Laboratories],  20%  methanol  [Sigma
Aldrich], 0.1% SDS [Biorad Laboratories] in DDW) for a 2
min and the proteins transferred upon high voltage of 400 mA
(25V) per 2 cm of gel area for 2 h. Membranes were blocked
with 10% BSA solution for 2 h at 4 °C. The goat anti-rat-IL-6
(19 kDa), -TNF-α (17 kDa), -MIP-2 (9 kDa) antibodies and
recombinant proteins (as a positive control for each protein;
eBioscience Inc.,) were diluted according to manufacturer’s
recommendations, in 10% BSA (Sigma Aldrich) blocking
solution. The solution was then added to the membranes and
incubated on rocker/shaker at 4 °C, overnight. Membranes
were washed and labeled with donkey anti-goat IgG-HRP
conjugated  (Jackson,  West  Grove,  PA)  antibody.  The
enhanced  chemilumiscent  (ECL;  Pierce  Biotechnology,
Rockford, IL) reagent was added to the membranes. Films
were developed and analyzed.
Measurement of cytokine levels in serum: Serum cytokine
levels were measured at 1 h, 3 h, 6 h, 12 h, 24 h, 7 days, and
21  days  after  CRAO  induction.  Immediately  following
euthanasia, peripheral blood was collected. The plasma was
separated by centrifugation and stored at −70 °C. Levels of
IL-6, TNF-α, and MIP-2 were measured simultaneously using
an ELISA kit (R&D, Minneapolis, MN).
Statistical analysis: Cytokine expression in the retina was
evaluated  by  using  the  student's  t-test,  to  compare  the
moderate and severe occlusion groups. Significance was set
at p<0.05. Mann–Whitney nonparametric tests were used to
compare findings between different time points. Student's t-
test was used to compare serum cytokine levels at different
time points and with control levels.
RESULTS
Gene  expression  of  cytokines  in  the  retina:  Relative
quantitative analysis of cytokine expression by real time RT–
PCR revealed similar trends in the mice that underwent high-
intensity (150 mW power) and moderate-intensity (100 mW
power)  laser  photoactivation.  There  was  no  statistically
significant difference between them for any of the cytokines
at any time point. Therefore, for the remainder of the study,
these two groups were analyzed jointly.
Gene  expression  of  cytokines  in  the  ischemic  eyes
showed wide variability, as outlined in Table 2. Absolute
expression of cytokines in the left control eyes was low to
undetectable  and  remained  so  at  all  time  points.  The
expression in the ischemic eyes relative to the levels in the
control (untreated) eyes is shown in Figure 1.
Mean levels were calculated for all samples at each time
point in the ischemic eyes. However, our analysis of the data
showed that the trends in cytokine expression identified by the
change in the majority of samples at each time point were not
always reflected by the mean values. These trends are also
presented and discussed.
The expression of the cytokines was further verified in
the retinal tissue by western blot analysis. Results are detailed
for each cytokine, and presented in Figure 2.
MIP-2—At  3  h  after  CRAO  induction,  mean  MIP-2
mRNA expression in the ischemic eyes was 0.9±1.2 fold of
the  expression  in  the  control  (untreated)  eyes.  Detailed
analysis  revealed  that  in  7  of  the  9  samples,  levels  were
actually low, with a mean level of 0.35±0.2 fold of control
level (range 0.08–0.65). At 12 h, mean levels peaked to 14±15
fold of controls (p<0.01, compared to the expression in the
ischemic eyes at 3 h). Elevated expression was found in 10 of
11 samples to 2–50 fold of controls. Expression was still high
at 24 h in all 4 samples examined at that time point (range 4–
29 fold of controls, mean 12±12 fold; p<0.01, compared to the
expression at 3 h). At 7 days, mean MIP-2 mRNA expression
significantly decreased to 2.7±6.7 fold of controls (p=0.02,
compared to the expression at 24 h). In 7 of 9 samples, levels
were  below  control  levels  (mean  reduced  levels  0.3±0.2,
p<0.01; Figure 1A).
Western blot analysis demonstrated cytokine presence in
all studied samples. MIP-2 was evident at 3 h, with maximal
band intensity at 12 h, and hardly visible at 7 days (Figure 2)
IL-6—At 3 h after CRAO induction, mean expression of
IL-6 mRNA was 2.9±5.24 fold of the control level. On detailed
analysis of the data, we found that in 6 of 9 samples, the
relative expression of IL-6 was actually lower (mean 0.5±0.1
fold of control levels). IL-6 mRNA mean expression at 12 h
increased to 20±11 fold of controls (p<0.01). Elevation was
noted in 8 of 9 samples to 10–39-fold of controls values. Mean
levels peaked at 24 h to 72±78 fold (p=0.02 compared to the
expression at 3 h). Expression was high in 3 of 4 samples (48–
183 fold of controls). At 7 days, the expression of IL-6 mRNA
was undetectable in most samples (p<0.01, compared to the
expression at 24 h; Figure 1B).
Western blot analysis demonstrated that IL-6 was present
in the retina at 3 h. Band intensity increased at 12 h, and was
hardly visible at 7 days. (Figure 2)
TNF-α—At  3  h  after  CRAO  induction,  the  relative
expression of TNF-α in the retina increased by a mean of
2.7±3.3 fold of control values. A further elevation was noted
at 12 h (mean 4.2±7.0). At 24 h, there was a gradual reduction
(mean 3.3±1.2 fold), which reached near-control levels at 7
days (mean 1.1±1.0). The difference in expression at 24 h and
7 days was statistically significant (p=0.033; Figure 1C).
Western blot analysis demonstrated the presence of TNF-
α in the retina at all time points measured, with high intensity
at both 3 h and 12 h. A slight decrease, however, still present,
at 7 days (Figure 2)
Serum  levels  of  proinflammatory  cytokines:  Serum  levels
were measured only in the mice treated with the high-intensity
laser.  Our  previous  experience  in  ischemic  conditions
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887Figure 1. Relative mRNA expression of
proinflammatory cytokines in ischemic
eyes  compared  to  control  eyes  at
variable  time  intervals  from  CRAO
induction. A: Elevated levels of MIP-2
at  12  h  and  24  h  are  statistically
significantly higher than the levels at 3
h and 7 days (p<0.01). Light bar in the
3 h column represents total mean value,
and the dark bar represents the trend of
reduced expression. The bars at 12 h, 24
h, and 7 days display the mean values
which represent the trends as well. B:
Levels of IL-6 peaked at 12 h and 24 h.
The differences between levels at 3 h
and 12 h, as well as between 3 h and 24
h were statistically significant (p<0.01,
0.02,  respectively).  Levels  at  7  days
were  statistically  significantly  lower
than levels at 24 h (p<0.01). Light bar in
the 3 h column represents total mean
value, and the dark bar represents the
trend of reduced expression. The bars at
12 h, 24 h, and 7 days display the mean
values  which  represent  the  trends  as
well. C: Level of expression of TNF-α
at  24  h  was  statistically  significantly
different  from  expression  at  7  days
(p=0.033).  The  asterisk  indicates
statistical  significance.  Error  bars
represent SD.
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888revealed large variability in cytokines' blood levels. Thus,
more conclusive results were expected in the more intense
ischemic condition [11,12]. Three to 4 mice were used for
each time point. Mean values of the temporal changes are
presented in Figure 3.
MIP-2—Already at 1 h after CRAO induction, the mean
serum level of MIP-2 was significantly elevated (212.2±83.3
pg/ml) compared to values in naive mice (50.7±31.7 pg/ml)
and mice treated with rose bengal only (83.0±35.2 pg/ml;
p=0.03). By 3 h, levels returned to control values, and then
remained low throughout the rest of the follow-up period, up
to 3 weeks after induction (Figure 3A).
IL-6—Serum  IL-6  levels  increased  later  than  MIP-2
levels,  at  3  h  after  CRAO  induction,  and  they  remained
TABLE 2. MRNA EXPRESSION OF CYTOKINES IN THE RETINA: MIP-2, IL-6, 
MIP-2
3 h 12 h 24 h 7 days
n=7 n=10 n=4 n=7
0.65 2.3 3.93 0
−3.93 4.24 29.04 0.36
0.44 −0.3 2.11 0.03
0.08 35.3 14.12 0.39
−1.58 5.54 0.2
0.28 11 −20.4
0.21 20.25 0.16
0.49 11.43 0.6
0.34 11.43 −1.95
3.32
49.69
IL-6
3 h 12 h 24 h 7 days
n=6 n=8 n=3 n=7
0.68 −1.15 56.1 0
0.6 21.86 182.91 0
−16.5 17.21 47.83 0
0.41 10.2 −1.36 0
−3.14 38.85 0.4
−3.36 25.36 0.09
0.315 21.18 0.77
0.6 30.06
0.47 16.22
TNF-α
3 h 12 h 24 h 7 days
n=5 n=7 n=4 n=6
−0.008 −0.59 2.52 0.25
5.52 1.55 4.87 1.87
1.56 −0.63 2.24 0.37
1.01 13.74 3.49 0.15
7.97 2.11 2.58
7.62 1.25 1.42
−0.11 1.54
−0.43 1.94
−0.54 −0.83
−0.34
22
Relative expression of mRNA of cytokines in the retina of the ischemic eyes, as compared to the left untreated control eye
(MIP-2, IL-6, TNF-α), at different time intervals from CRAO induction. The marked numbers represent extreme points which
did not follow the trend determined by the majority of samples at each time point. The number of samples at each time point
refers to the samples which comprise the majority determining the trend.
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  TNF-α.elevated for up to 12 h after the ischemic event. There was a
statistically significant difference in IL-6 levels between the
study mice and the two control groups at 3 h (136.5±61.3 pg/
ml versus 4.9±3.7 pg/ml (naìve mice) and 27.6±20.8 pg/ml
(rose bengal injected mice) ; p=0.02). A sharp decline in serum
levels was found at 24 h, and levels remained low for the next
3 weeks (Figure 3B).
TNF-α—TNF-α  showed  a  biphasic  pattern  in  serum:
Mean levels were elevated already 1 h after CRAO induction
(28.54±9.1  pg/ml)  compared  to  values  in  naïve  mice
(11.53±20.0 pg/ml; p=NS) and mice treated with rose bengal
only  (5.9±8.0  pg/ml;  p=0.03).  Additional  peaks  were
measured at 24 h (17.9±26.4 pg/ml) and at 1 week (23.1±32.6
pg/ml; Figure 3C). The differences between TNF-α levels at
1 h, 6 h, 12 h, and 3 weeks were statistically significant
(p=0.03).
DISCUSSION
This study demonstrates the temporal changes that take place
in  the  levels  of  different  proinflammatory  cytokines  after
CRAO induction and their interrelationships, locally in the
retina and systemically in the serum. Most of the changes in
serum levels occurred within the first 24 h after the ischemic
event (Figure 3): MIP-2 and TNF-α levels peaked early and
dropped shortly thereafter, with a second late elevation of
TNF-α;  IL-6  rose  when  MIP-2  and  TNF-α  declined  and
remained high for up to 12 h. These findings are in line with
previous reports of an immediate elevation in serum cytokine
levels  after  ischemic  reperfusion  insult.  Studies  of  acute
myocardial ischemia reported an increase in systemic levels
of IL-8, IL-6, and TNF-α [14,17,24], peaking (IL-8 and IL-6)
3 h to 6 h later [6,7]. The changes correlated with the amount
of damage and disease outcome, and the systemic elevation
in TNF-α served as an independent determinant of reperfusion
injury  after  acute  myocardial  infarction  [25].  Correlations
between severity of ischemic damage and cytokines levels
was also found for IL-8 and TNF-α in patients with acute
stroke [26] and for IL-6 and IL-8 in asphyxiated neonates
[27].
In the retina, patterns of gene expression at the mRNA
levels are expressed by mean values. However, because of the
presence of a few extreme values, the means may not reflect
real trends of expression. Therefore, we believe that is more
appropriate to determine trends using the majority of samples
that show a change in a certain direction. In the present study,
mRNA levels of MIP-2 and IL-6 were low at 3 h, while TNF-
α levels increased. All cytokines increased at 12–24 h, and
declined  thereafter  (Figure  1).  At  the  protein  level,  all
cytokines were present in the retina at 3 h, and later followed
the expression pattern of their respective mRNA. Only a few
previous studies measured cytokine levels in the retina in
various models of eye diseases. One found that TNF-α was
the most prominent cytokine after transient ischemia in the rat
retina, showing an upregulation of gene expression within
0.5–48 h after the insult, and a peak at 12 h [28]. Another study
localized upregulation of various chemotactic cytokines first
to the retinal vasculature, and later to the inner retinal layers
[29].
In an earlier study of patients with CRAO by our group
[12], there was an increase in serum levels of IL-8, IL-6, and
TNF-α within the first 3 h after the ischemic event, followed
by a significant decline, with no temporal variance among the
different cytokines. At the onset of CRAO, samples taken
from the aqueous humor showed an early elevation in IL-8
and TNF-α levels followed by a sharp decline, whereas IL-6
Figure 2. Western blot analysis of cytokines in retinal samples at
different time points. Western blot analysis of the cytokines in pooled
retinal samples, using goat anti–rat antibodies. Recombinant proteins
were used for each cytokine as positive control. The proteins were
separated using SDS–PAGE. Labeling was performed using donkey
anti goat IgG HRP conjugated antibody. Films were developed using
ECL reagent. A: Western blot analysis demonstrated the presence of
TNF-α at all time points measured with high intensity bands at both
3 h and 12 h. A slight decrease occurred at 7 days. B: Western blot
analysis of IL-6 demonstrated the presence of the cytokine in the
retina at 3 h. Band intensity increased at 12 h, and was hardly visible
at 7 days. C: Western blot analysis of MIP-2 demonstrated the
presence of the cytokine in all studied samples. MIP-2 was evident
at 3 h, with maximal band intensity at 12 h, and hardly visible at 7
days. PC represents positive control.
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trends as in our experimental model. Locally, TNF-α followed
the same trends in the mouse retina and in patients. IL-6 and
MIP-2 were present in the mouse retina early, while their
mRNA was upregulated only 12 h later. Albadawi et al. [30]
showed  that  only  prolonged  ischemia  (6  h)  followed  by
reperfusion  could  increase  the  steady-state  levels  of  IL-8
mRNA, and that during ischemia, stored IL-8 may be released
nonspecifically while de novo synthesis takes over. Thus, it is
possible that in patients with CRAO, the systemic elevation
of IL-8 levels, as well as their early local increase, may be due
initially to the release of stored intracellular IL-8, and only
later to de novo synthesis. Therefore, it may also be that in our
experimental  model,  preexisting  IL-6  and  MIP-2  were
secreted, and detected within the retina, while new production
occurred later when mRNA was upregulated.
Proinflammatory  cytokines  may  play  a  role  in  the
preservation  of  the  tissue  or  in  its  destruction.  Following
ischemia-reperfusion  injury,  proinflammatory  mediators
affect neuroprotection and neurotoxicity processes [30–32].
IL-8 (or its mouse equivalent MIP-2) activates chemotaxis
and adhesion of neutrophils to the endothelial cell surface,
causing a paradoxical increase in the tissue injury [26,31]. An
increase  in  IL-8  mRNA  expression  and  immunoreactive
protein levels was also reported in vascular layers of ischemic
retina in rodents [29], similar to our findings of increased
retinal expression of MIP-2 mRNA 12 h after induction of
ischemia, followed by increased levels of the cytokine.
Under  conditions  of  ischemia-reperfusion,  IL-6  has  a
neuroprotective effect [33–35] and is considered an important
endogenous inhibitor of neuronal death [36]. Clinical studies
have shown that IL-6 levels peak within 12 h of ischemic
stroke and stimulate other protective mediators [36]. These
findings  were  supported  by  experimental  studies  [24].
However, IL-6 may also cause neurotoxicity [37] in the first
24 h following injury. We found that IL-6 mRNA in the retina
was down-regulated early after CRAO induction. However,
IL-6  was  already  detected  within  the  retinal  tissue.  IL-6
mRNA levels rose only after MIP-2 and TNF-α mRNA levels
decreased. Other researchers reported high local expression
of IL-6 following ischemia in organs such as heart [5] or brain
[6], and in a rat model of ocular [28] and brain ischemia
[35]. It is possible that the early presence of IL-6 in the retina
may exert a neurotoxic effect, but the early downregulation of
IL-6 mRNA, as well as its delayed increase, may exert a
neuroprotective effect. Since in normal conditions, IL-6 levels
in the eye are very low to undetectable, the systemic elevation
may be caused by a remote effect rather than direct spillover
from the eye.
TNF-α, an early strong immune mediator, is produced by
astrocytes,  microglia,  and  neurons.  It  is  expressed  upon
exposure to various stimuli, including ischemia and ischemia-
reperfusion injury. We found a biphasic elevation of TNF-α
Figure 3. Serum levels of proinflammatory cytokines are expressed
in pg/ml, relative to time interval from CRAO induction. The square-
interspersed  line  indicates  the  control  level  in  naìve  mice.  The
triangle-interspersed line indicates the control level in rose-bengal-
injected  mice.  Error  bars  represent  SD.  The  asterisk  indicates
statistical significance. The specific values are detailed for each
cytokine separately. A: MIP-2 Levels were elevated at 1 h. The level
at 1 h was statistically significantly higher than levels thereafter
(p=0.03). B: IL-6 levels increased at 3 h and remained elevated at 6
h and 12 h. The elevated levels were statistically significantly higher
than levels of both control groups (p=0.02, 0.03 and 0.003 for 3 h, 6
h, and 12 h, respectively). C: TNF-α showed an early peak at 1h and
late elevation at 1week and 3 weeks. Statistical significance was
found only between the early peak and the control levels of rose
bengal injected mice.
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in the serum and an increase in the retina, both at the mRNAand at the protein levels within 24 h. TNF-α was reported to
be upregulated in the brain after injury, and its excessive
synthesis was correlated with poor prognosis; inhibition of
TNF-α expression reduced brain damage [38,39]. Researchers
have suggested that TNF-α induces vascular inflammation
leading to vascular endothelial dysfunction [40]. It apparently
induces apoptotic cell death, and, specifically, neuronal cell
death  in  the  retina  via  TNF-receptor  −1  [41].  In  cerebral
ischemia, TNF-α probably has a dual function: neurotoxicity
via  upregulation  of  inducible  nitric  oxide  synthase,  and
neuroprotection in the absence of nitric oxide synthase [42].
Thus, given that proinflammatory cytokines participate
in  both  the  preservation  and  destruction  of  post-ischemic
tissue, therapeutic solutions should take these diverse effects,
by time and conditions, into account. Some studies suggest
that anti-IL-8 therapy may interfere with the mobilization of
neutrophils  and  inflammatory  cells  during  reperfusion,
thereby reducing ischemic damage. The inhibition of IL-8 in
an experimental model of transient brain ischemic injury led
to a decrease in neutrophil infiltration [43]. However, since
IL-8 is also involved in the process of homing and mobilizing
stem cells to the area of injury, blocking its expression could
have adverse effects [44].
Anti-TNF-α agents are clinically available. Their use has
been  found  in  experimental  models  to  reduce  ischemic
damage in myocardium [45,46] and lung [47]. Some of the
therapeutic  effect  of  antiplatelet  agents  in  brain  ischemia
involves modulation of TNF–α [26].
The  present  CRAO  mouse  model  is  amenable  to  the
measurement of in situ and serum levels of expression of
proinflammatory  cytokines  after  ischemic  retinal  damage.
However,  because  cytokine  measurement  is  difficult,  and
baseline  levels  are  almost  undetectable,  we  found  a  high
variability in the samples analyzed. When we enlarged the
study group, we were able to identify trends, but had to ignore
extremes; we were unable to optimize the systems even by
comparing two different intensities of injury. Nevertheless,
the trends detected were similar to those previously reported
in patients with CRAO. A second limitation of the study was
the absence of data on changes in cytokine levels in remote
organs. Recently, researchers reported the upregulation of
cytokines also in uninvolved tissues—for example, a high
expression of TNF-α in the brain following cardiac ischemia
[48] and trauma [49]. The authors speculated that this effect
was  mediated  by  the  sympathetic  and  parasympathetic
nervous systems, and not by direct blood-borne mediators.
In  conclusion,  the  trend  in  the  changes  in  cytokine
expression in the retina and serum during ischemia induced
by  retinal  artery  occlusion  resemble  previous  findings  in
humans and may affect the severity of damage and, thereby,
outcome. The absence of IL-6 mRNA early after the ischemic
event and its later expression may indicate a protective role.
MIP-2 and TNF-α may be involved in worsening the ischemic
damage.  Therefore,  therapeutic  strategies  should  take  the
timely modulation of these cytokines into account.
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